Lung cancer rates have surged in woman after tobacco manufacture, encouraged them to smoke for staying slim and beautiful, experts say.
By comparison the numbers of men diseases will rise by 8%, from 40,000 to 45,000. The surge means that there will be more then twice as many women with this disease than men.
Lung cancer is the third most common form of illness in woman after bowel and breast, but it is one of the deadliest.
Fewer than 15% of patients can expect to live beyond five years largely because the illness is usually diagnosed so late.
It is also the biggest cause of death in Britain claiming 40,000 lives each year, more than heart disease or any other type of cancer.
But researchers say that while rates in men are beginning to stabilize, they are still increasing very quickly in women.
This is because lung cancer rates tend to reflect people’s smoking habits of 40 to 40 years ago.
Woman didn’t smoke until 1960’s and 1970’s targeted by advertisement promoting aspiration and glamour.
Amanda Standford of Smoking Action and health affirmed that many manufacturers used images with beautiful, healthy and thin models and equally with slim cigarettes.
She added: “Smoking was associated with being attractive and thin. Even any of the brands use the name slim such as Virginia Slim Cigarettes being American brand. Although tobacco ads
Although tobacco ads have been banned, manufacturers still promoted smoking with by being slim, marketing feminine cigarettes.
Woman was a little bit slower for to take smoking up as they are slower to get the consequences, like lung cancer, being a delayed reaction.
The researchers, whose study is published in the British Journal of Cancer, saying that there will be present 137,000 of people with lung disease by 2040.
The researchers, whose study is published in British Journal of Cancer.
This increase is due to combination of the smoking effects that aging population – lung cancer is more common in the over 50s.
They affirmed that by around 2020, there will be more female then male with lung cancer.
But campaigners warn that not enough findings is being put better methods of treatment and diagnosis.
It receives a quarter of the amount dedicated to breast cancer even though claims more than four times.
“Lung Cancer is often overlooked among cancers but these figures should serve as a firm reminder that is a cancer killer, said Ciaran Devane.
“For most cancers diseases in the UK we are looking at how we can cope with population in long term survivors with health complications. We are long away from lung cancers and from being able to consider these tasks.
“Lung cancer survival needs to improve. Prevention is important as researchers are for treatments and diseases. It is without sense that research in this area receives such minimal funding in comparison with other cancers. It should be changed”